Fate Therapeutics
FATE
FATE
181 hedge funds and large institutions have $642M invested in Fate Therapeutics in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 73 increasing their positions, 55 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
33% less call options, than puts
Call options by funds: $247K | Put options by funds: $368K
39% less capital invested
Capital invested by funds: $1.06B → $642M (-$418M)
69% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 67
Holders
181
Holding in Top 10
2
Calls
$247K
Puts
$368K
Top Buyers
| 1 | +$53.7M | |
| 2 | +$18M | |
| 3 | +$16.3M | |
| 4 |
BlackRock
New York
|
+$10.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$10.1M |
Top Sellers
| 1 | -$56.4M | |
| 2 | -$42.5M | |
| 3 | -$14M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$9.16M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
-$9.15M |